Hypothesis · not a trading signal
FY2026 / Q4-end RPO · Published 2026-06-10 · Source checked 2026-09-06
- 01 / What the issuer reported
- RPO reached $638bn; full-year free cash flow was negative $23.7bn. Customer-prepaid/provided hardware in large AI contracts totaled $75bn.
- 02 / Our hypothesis — not established alpha
- Customer funding may reduce financing pressure, but backlog value depends on payment, capacity delivery and residual obligations.
- 03 / What to measure next
- RPO maturity/counterparties, cash receipts, customer hardware, debt, leases and OCI operating economics.
- 04 / What would challenge the thesis
- Reassess after material deferrals, adverse contract revisions or financing needs that dilute per-share value.
- 05 / Appropriate valuation method
- Contract-aware DCF with funding scenarios; RPO cannot be added to equity value at face value.
- 06 / Still missing
- Missing: contract-level cash schedules and credit exposure, not just aggregate RPO.
No measured consensus gap or approved price target. A familiar good business can still be an expensive stock.